UBS analyst Trung Huynh lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $560.00 (from $633.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE